Key Insights

Highlights

Treatment Research

5 treatments under study, led by Nodulectomy

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06070116Phase 2Active Not RecruitingPrimary

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

NCT05868551UnknownPrimary

Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study

Showing all 2 trials

Research Network

Common Treatments

  • Nodulectomy1
  • Ivermectin Diethylcarbamazine Albendazole1
  • Moxidectin Albendazole1
  • Moxidectin Diethylcarbamazine Albendazole1
  • Ivermectin W Albendazole1

Active Sponsors

  • Amref Health Africa1
  • Universiteit Antwerpen1
  • National Public Health Institute of Liberia1
  • Washington University School of Medicine1

Top Investigators

Related Conditions

  • Virus1
  • Onchocerciasis1
  • Tropical Disease1
  • Onchocerca Infection1
  • Onchocerciasis Ocular1

Activity Timeline